or Try an Advanced Search...

    ETF Components for CVRT - Calamos Convertible Equity Alternative ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NEE C 1.42 2.78
    NTRA B -3.34 0.99

    Represented by ETF Holdings

    Keywords: Acid Applied Genetics Clinical Medicine DNA DNA Paternity Testing Electric Energy Electricity Genetic Diseases Genetic Testing Gexa Energy IBD 50 In Vitro Lab Testing Medical Genetics Medical Test Medicine Natural Gas Nextera Energy Nextera Energy Partners Prenatal Testing
    Industries: Diagnostics & Research Utilities - Regulated Electric

    Recent News for Calamos Convertible Equity Alternative ETF & its Holdings

    Date Stock Title
    Nov 15 NTRA Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets
    Nov 15 NTRA Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024
    Nov 15 NEE Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom
    Nov 14 NTRA Druckenmiller's Duquesne closes some media holdings, loads into regional banks, among Q3 trades
    Nov 14 NTRA Natera Third Quarter 2024 Earnings: Beats Expectations
    Nov 13 NEE NextEra Energy (NEE): Balancing AI Power Demand and Capital Challenges
    Nov 13 NTRA Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started?
    Nov 13 NTRA Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday
    Nov 13 NEE Here is What to Know Beyond Why NextEra Energy, Inc. (NEE) is a Trending Stock
    Nov 13 NEE NextEra Energy Gains Momentum as Major Investors Strengthen Positions
    Nov 13 NTRA Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ...
    Nov 13 NTRA Decoding Natera Inc (NTRA): A Strategic SWOT Insight
    Nov 13 NTRA Natera, Inc. (NTRA) Q3 2024 Earnings Call Transcript
    Nov 12 NTRA Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
    Nov 12 NTRA Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
    Nov 12 NTRA Natera stock jumps 11% post-market on Q3 earnings, raised guidance
    Nov 12 NTRA Natera: Q3 Earnings Snapshot
    Nov 12 NTRA Natera GAAP EPS of -$0.26 beats by $0.33, revenue of $439.76M beats by $78.63M
    Nov 12 NTRA Natera Reports Third Quarter 2024 Financial Results
    Nov 12 NTRA Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
    The fund is an actively managed exchange-traded fund (ETF) that invests in the segment of the U.S. convertibles marketplace that has a higher level of equity sensitivity. The fund seeks to achieve its objective by investing at least 80% of its net assets (plus borrowings for investment purposes, if any) in a portfolio of convertible securities (including synthetic convertible instruments). The fund is non-diversified.
    Exchange Traded Funds Investment Management Betashares Advisorshares
    Back to the Main CVRT Page...